LDN: The Anti-Inflammatory and Longevity Potential of Low Dose Naltrexone

LDN: The Anti-Inflammatory and Longevity Potential of Low Dose Naltrexone by The FINANCIAL  March 3, 2025 https://finchannel.com/ldn-the-anti-inflammatory-and-longevity-potential-of-low-dose-naltrexone/124870/business-2/2025/03/ Low Dose Naltrexone (LDN) is emerging as a promising tool in longevity science. Originally approved to treat opioid addiction in high doses, researchers have discovered that at lower doses, naltrexone plays a key role in reducing inflammation, modulating […]